Aquilo Capital Management LLC

Aquilo Capital Management LLC latest Q4_2020 13F filings reported $335,045,000 in market value on this 2021-02-16 report date . The portfolio quarterly return is 37.17%. This fund has 15 securities concentrations of 100% weights.

Aquilo Capital Management LLC largest holding is Spero Therapeutics Inc. with weight of 22.76% and $76,246,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.

Portfolio Performance History

FILE DATEREPORT PERIODQTR YEARFILE TYPENOS. OF STOCKSREPORTED VALUERETURN
2021-02-162020-12-31Q4_202013F-HR15$335,045,00037.17%
2020-11-162020-09-30Q3_202013F-HR15$244,247,000-10.21%
2020-08-142020-06-30Q2_202013F-HR13$272,017,00051.85%
2020-05-152020-03-31Q1_202013F-HR13$179,141,00021.58%
2020-02-142019-12-31Q4_201913F-HR11$147,349,00067.20%
2019-11-142019-09-30Q3_201913F-HR9$88,130,000-34.79%
2019-08-142019-06-30Q2_201913F-HR11$135,141,0008.33%
2019-05-152019-03-31Q1_201913F-HR12$124,754,00026.03%
2019-02-142018-12-31Q4_201813F-HR13$98,991,000-25.84%

Portfolio Details

Stock NameTickersValueCurrent Value (x1000)Change Value %WeightComputed PriceShares Change %Current Shares
SPERO THERAPEUTICS INCSPROINCR$76,24651.92%22.76%$19.39-112.56%3,932,209
BLUEPRINT MEDICINES CORPBPMCINCR$42,61819.19%12.72%$112.15-101.48%380,012
NGM BIOPHARMACEUTICALS INCNGMINCR$30,46388.02%9.09%$30.30-101.26%1,005,534
DICERNA PHARMACEUTICALS INC COMMON STOCK USD0.0001DRNAINCR$29,85920.73%8.91%$22.03-101.41%1,355,392
ARROWHEAD PHARMACEUTICALS INARWRINCR$28,07824.58%8.38%$76.73-130.09%365,926
ANAPTYSBIO INCANABINCR$26,14319.95%7.80%$21.50-117.71%1,215,958
UNIQURE NVQUREINCR$25,3659.13%7.57%$36.13-88.75%702,050
REGENXBIO INCRGNXINCR$22,83662.46%6.82%$45.36-101.43%503,444
MAGENTA THERAPEUTICS INCMGTAINCR$17,769172.57%5.30%$7.8436.43%2,266,423
AMRYT PHARMA PLCAMYTBUY$11,3280.00%3.38%$14.160.00%800,000
PIERIS PHARMACEUTICALS INCPIRSINCR$9,18920.78%2.74%$2.50-100.00%3,675,530
GALAPAGOS NV SPON ADRGLPGINCR$6,92850.05%2.07%$98.9915.13%69,989
ARGENX SE - ADR 1 ORDARGXINCR$3,73589.69%1.11%$294.09-30.67%12,700
GENMAB A/SGMABINCR$3,65999.84%1.09%$40.66-20.00%90,000
4D MOLECULAR THERAPEUTICS INFDMTBUY$8290.00%0.25%$41.450.00%20,000
AC IMMUNE SAACIUSOLD$00.00%-100.00%$0.000.00%0
ISHARES TRIWMSOLD$00.00%-100.00%$0.000.00%0
PROQR THRAPEUTICS N V PRQRSOLD$00.00%-100.00%$0.000.00%0